Home > Boards > US Listed > Medical - Drugs > Dr. Reddy's Laboratories Limited (RDY)

Source: IRIS (05 May 2008)

Public Reply | Private Reply | Keep | Last ReadPost New MsgNext 10 | Previous | Next
buhg1b Member Profile
 
Followed By 8
Posts 737
Boards Moderated 0
Alias Born 05/03/07
160x600 placeholder
Report of Foreign Issuer Pursuant to Rule 13a-16 or 15d-16 (6-k) Edgar (US Regulatory) - 3/1/2021 10:18:54 AM
Dr. Reddy's requested by India to give more data for Sputnik V approval Seeking Alpha - 2/25/2021 11:07:03 AM
Report of Foreign Issuer Pursuant to Rule 13a-16 or 15d-16 (6-k) Edgar (US Regulatory) - 2/22/2021 7:14:42 AM
Dr. Reddy's launches generic Prevacid SoluTab tablets in U.S. Seeking Alpha - 2/22/2021 3:06:02 AM
Dr. Reddy's Laboratories Announces the Launch of Lansoprazole DR Orally Disintegrating Tablets in the U.S. Market Business Wire - 2/22/2021 1:13:00 AM
Report of Foreign Issuer Pursuant to Rule 13a-16 or 15d-16 (6-k) Edgar (US Regulatory) - 2/19/2021 8:25:51 AM
Dr. Reddy's seeks emergency use nod for Sputnik V in India Seeking Alpha - 2/19/2021 6:10:52 AM
Dr. Reddy's Initiates Process for Emergency Use Authorization of Sputnik V Business Wire - 2/19/2021 5:45:00 AM
Report of Foreign Issuer Pursuant to Rule 13a-16 or 15d-16 (6-k) Edgar (US Regulatory) - 2/18/2021 8:09:04 AM
Dr. Reddy's launches generic Prolixin tablets in U.S. Seeking Alpha - 2/18/2021 3:36:49 AM
Dr. Reddy's Laboratories announces the launch of Fluphenazine Hydrochloride Tablets, USP in the U.S. Market Business Wire - 2/18/2021 1:50:00 AM
Report of Foreign Issuer Pursuant to Rule 13a-16 or 15d-16 (6-k) Edgar (US Regulatory) - 2/17/2021 6:31:19 AM
Dr. Reddy's launches generic capecitabine tablets in U.S. Seeking Alpha - 2/17/2021 5:21:18 AM
Dr. Reddy's Laboratories Announces the Launch of Capecitabine Tablets, USP in the U.S. Market Business Wire - 2/17/2021 5:11:00 AM
Report of Foreign Issuer Pursuant to Rule 13a-16 or 15d-16 (6-k) Edgar (US Regulatory) - 2/3/2021 11:32:50 AM
Report of Foreign Issuer Pursuant to Rule 13a-16 or 15d-16 (6-k) Edgar (US Regulatory) - 2/2/2021 7:16:34 AM
Amended Statement of Ownership (sc 13g/a) Edgar (US Regulatory) - 2/2/2021 7:06:51 AM
Dr. Reddy's Laboratories Announces the Launch of Vigabatrin Tablets, USP in the U.S. Market Business Wire - 2/2/2021 4:20:00 AM
Report of Foreign Issuer Pursuant to Rule 13a-16 or 15d-16 (6-k) Edgar (US Regulatory) - 1/29/2021 8:10:04 AM
Dr. Reddy’s Q3 & 9M FY21 Financial Results Business Wire - 1/29/2021 4:37:00 AM
Report of Foreign Issuer Pursuant to Rule 13a-16 or 15d-16 (6-k) Edgar (US Regulatory) - 1/27/2021 9:08:09 AM
Dr. Reddy’s and GRA announces Avigan Pivotal Studies Update Business Wire - 1/27/2021 5:02:00 AM
Dr. Reddy’s Receives Approval to Conduct Phase 3 Clinical Trial for Sputnik V Vaccine in India Business Wire - 1/15/2021 12:33:00 PM
Sputnik V meets the primary endpoint of safety in the Phase 2 Clinical Trial in India Business Wire - 1/11/2021 10:25:00 AM
Report of Foreign Issuer Pursuant to Rule 13a-16 or 15d-16 (6-k) Edgar (US Regulatory) - 1/11/2021 8:48:27 AM
buhg1b   Monday, 05/05/08 11:21:54 AM
Re: None
Post # of 19 
Source: IRIS (05 May 2008)

Dr Reddy`s Laboratories allotted 2,870 equity shares of Rs 5 each of the company on May 03, 2008, to company employees under the Dr. Reddy`s Employees Stock Option Scheme, 2002.

In addition, the compensation committee of the board of directors of the company has allotted 17,604 ADRs of Rs 5 each on May 03, 2008, to the US employees of the company under Dr. Reddy`s Employees ADR Stock Option Scheme, 2007.

Dr. Reddy`s is a vertically integrated, global pharmaceutical company with proven research capabilities and presence across the pharmaceutical value chain. It manufactures active pharmaceutical ingredients (APIs) and finished dosage forms and markets them globally, with a focus on United States, Europe, India and Russia.

Shares of the company gained Rs 6, or 0.95%, to settle at Rs 638.45. The total volume of shares traded was 31,724 at the BSE (Monday).

http://www.myiris.com/newsCentre/newsPopup.php?fileR=20080505180745181&dir=2008/05/05&secID=livenews

Public Reply | Private Reply | Keep | Last ReadPost New MsgNext 10 | Previous | Next
Follow Board Follow Board Keyboard Shortcuts Report TOS Violation
X
Current Price
Change
Volume
Detailed Quote - Discussion Board
Intraday Chart
+/- to Watchlist
Consent Preferences